Publique en esta revista
Información de la revista
Vol. 46. Núm. S7.Octubre 2010
Neumología de urgencias
Páginas 1-37
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 46. Núm. S7.Octubre 2010
Neumología de urgencias
Páginas 1-37
DOI: 10.1016/S0300-2896(10)70041-7
Guía ALERTA 2. América Latina y España: Recomendaciones para la prevención y el Tratamiento de la exacerbación Asmática
Visitas
26820
Gustavo J. Rodrigoa, Vicente Plaza Moralb,??
Autor para correspondencia
vplaza@santpau.cat

Autor para correspondencia.
, Santiago Bardagí Fornsc, José A. Castro-Rodríguezd, Alfredo de Diego Damiáe, Santos Liñán Cortésf, Carlos Melero Morenog, Luis J. Nanninih, Hugo Neffeni, Jorge Salasj
a Departamento de Emergencia, Hospital Central de las Fuerzas Armadas, Montevideo, Uruguay; Departamento de Asma de la Asociación Latinoamericana del Tórax (2006–2008), Montevideo, Uruguay
b Servicio de Neumología, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Área de Asma de la Sociedad Española de Neumología y Cirugía Torácica, Barcelona, España
c Unidad de Neumología, Hospital de Mataró, Sociedad Española de Neumología y Cirugía Torácica, Barcelona, España
d Escuela de Medicina, Pontificia Universidad Católica de Chile, Asociación Latinoamericana del Tórax, Santiago, Chile
e Servicio de Neumología, Hospital Universitario La Fe, Valencia, España, Sociedad Española de Neumología y Cirugía Torácica, Barcelona, España
f Servicio de Neumología Pediátrica, Hospital de Nens de Barcelona, Sociedad Española de Neumología y Cirugía Torácica, Barcelona, España
g Servicio de Neumología, Hospital Universitario 12 de Octubre, Madrid, España, Sociedad Española de Neumología y Cirugía Torácica, Barcelona, España
h Sección de Neumonología, Hospital G. Baigorria, Universidad Nacional de Rosario, Asociación Latinoamericana del Tórax, Santa Fe, Argentina
i Unidad de Medicina Respiratoria, Hospital de Niños O. Alassia, Asociación Latinoamericana del Tórax, Santa Fe, Argentina
j Instituto Nacional de Enfermedades Respiratorias, Departamento de Asma de la Asociación Latinoamericana del Tórax (2008–2010), México DF, México
Este artículo ha recibido
26820
Visitas
Información del artículo
El Texto completo solo está disponible en PDF
Bibliografía
[1.]
G.J. Rodrigo,V. Plaza,J. Bellido-Casado,H. Neffen,M.T. Bazús,G. Levy
Changes in the characteristics of patients hospitalized for acute asthma over a ten-year period (1994–2004) in Spain and Latin-America: the Eagle study
Brazilian J Pulmonology, 35 (2009), pp. 635-644
[2.]
G.J. Rodrigo
¿Están verdaderamente basadas en la evidencia las guías sobre el asma? Un análisis crítico
Arch Bronconeumol, 44 (2008), pp. 81-86
[3.]
G.J. Rodrigo,C. Rodrigo,J.B. Hall
Acute asthma in adults. A review
Chest, 125 (2004), pp. 1081-1102
[4.]
M. Chan-Yeung,J.H. Chang,J. Manfreda,A. Ferguson,A. Becker
Changes in peak flow, symptom score, and the use of medications during acute exacerbations of asthma
Am J Respir Crit Care Med, 156 (1996), pp. 889-893
[5.]
A.E. Tattersfield,D.S. Postma,P.J. Barnes,K. Svensson,C.A. Bauer,P.M. O’Byrne
Exacerbations of asthma: a descriptive study of 425 severe exacerbations
Am J Respir Crit Care Med, 160 (1999), pp. 594-599 http://dx.doi.org/10.1164/ajrccm.160.2.9811100
[6.]
E.M. Martínez-Moragón,A. Perpiñá,A. Belloch,A. De Diego,M.E. Martínez-Francés
Percepción de la disnea durante la broncoconstricción aguda en los pacientes con asma
Arch Bronconeumol, 39 (2003), pp. 67-73
[7.]
R. Magadle,N. Berar-Yanay,P. Weiner
The risk of hospitalization and near-fatal and fatal asthma in relation to the perception of dyspnea
Chest, 121 (2002), pp. 329-333
[8.]
M.O. Turner,K. Noertjojo,S. Vedal,T. Bai,S. Crump,J.M. Fitzgerald
Risk factors for near-fatal asthma. A case-control study in hospitalized patients with asthma
Am J Respir Crit Care Med, 157 (1998), pp. 1804-1809 http://dx.doi.org/10.1164/ajrccm.157.6.9708092
[9.]
V. Plaza,J. Serrano,C. Picado,J. Sanchis
Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma
Eur Respir J, 19 (2002), pp. 846-852
[10.]
J.M. Antó,J.M. Sunyer
Epidemic asthma
Difficult asthma, pp. 333-340
[11.]
P.G. Woodruff,S.D. Edmond,A.K. Singh,C.A. Camargo
Sudden-onset acute asthma: clinical features and response to therapy
Acad Emerg Med, 5 (1998), pp. 695-701
[12.]
G. Rodrigo,C. Rodrigo
Rapid-onset attack: a prospective study cohort about characteristics and response to emergency department treatment
Chest, 118 (2000), pp. 1547-1552
[13.]
L. Rubilar,J.A. Castro-Rodríguez,G. Girardi
Randomized trial of salbutamol via metered-dose inhaler with spacer versus nebulizer for acute wheezing in children less than 2 years of age
Pediatr Pulmonol, 29 (2000), pp. 264-269
[14.]
I. Otero González,M. Blanco Aparicio,C. Montero Martínez,P. Valiño López,H. Verea Hernando
Características epidemiológicas de las exacerbaciones por EPOC y asma en un hospital general
Arch Bronconeumol, 38 (2002), pp. 256-262
[15.]
S. Gartner,N. Cobos,E. Pérez Yarza,A. Moreno,S. Liñán,C. De Frutos
Estudio comparativo de la eficacia de deflazacor frente a prednisolona en el tratamiento de la crisis asmática moderada
An Pediatr (Barc), 61 (2004), pp. 207-212
[16.]
F. Morell,T. Genover,E. Benaque,C. Picado,X. Muñoz,M.J. Cruz
Incidencia y características de las agudizaciones asmáticas en Barcelona (ASMABII)
Arch Bronconeumol, 45 (2009), pp. 550-555 http://dx.doi.org/10.1016/j.arbres.2009.06.005
[17.]
D.M. Mannino,D.M. Homa,L.J. Akinbami,J.E. Moorman,C. Gwynn,S.C. Redd
Surveillance for asthma. United States, 1980–1999
MMWR CDC Surveill Summ, 51 (2002), pp. 1-13
[18.]
D.H. Smith,D.C. Malone,K.A. Lawson,L.J. Okamoto,C. Battista,W.B. Saunders
A national estimate of the economic costs of asthma
Am J Respir Crit Care Med, 156 (1997), pp. 787-793 http://dx.doi.org/10.1164/ajrccm.156.3.9611072
[19.]
J. Serra-Batlles,V. Plaza,E. Morejon,A. Comella,J. Brugues
Costs of asthma according to the degree of severity
Eur Respir J, 12 (1998), pp. 1322-1326
[20.]
K.B. Weiss,S.D. Sullivan,C.S. Lyttle
Trends in the cost of illness for asthma in the United States 1985–1994
J Allergy Clin Immunol, 106 (2000), pp. 493-499 http://dx.doi.org/10.1067/mai.2000.109426
[21.]
L. Borderías Clau,M. Zabaleta Murguionda,J.A. Riesco Miranda,C. Pellicer Ciscar,J.R. Hernandez Hernandez,T. Carrillo Días
Arch Bronconeumol, 41 (2005), pp. 313-321
[22.]
D. Getahun,K. Demissie,G.G. Rhoads
Recent trends in asthma hospitalization and mortality in the United States
J Asthma, 42 (2005), pp. 373-378 http://dx.doi.org/10.1081/JAS-62995
[23.]
V. Plaza,J. Serra-Batlles,E. Morejón,A. Comella,J. Brugués
Características clínicas y morbilidad en el asma estable. Análisis descriptivo del asma en una comunidad mediterránea
Arch Bronconeumol, 33 (1997), pp. 457-461
[24.]
I. Cerveri,F. Locatelli,M.C. Zoia,A. Corsico,S. Accordini,R. De Marco
International variations in asthma treatment compliance
Eur Respir J, 14 (1999), pp. 288-294
[25.]
R. Louis,L.C.K. Lau,A.O. Bron,A.C. Roldaan,M. Radermecker,R. Djukanovic
The relationship between airways inflammation and asthma severity
Am J Respir Crit Care Med, 161 (2000), pp. 9-16 http://dx.doi.org/10.1164/ajrccm.161.1.9802048
[26.]
S. Suissa,P. Ernst
Inhaled corticosteroids: impact on asthma morbidity and mortality
J Allergy Clin Immunol, 107 (2001), pp. 937-944 http://dx.doi.org/10.1067/mai.2001.115653
[27.]
I. Mitchell,S.C. Tough,L.K. Semple,F.H. Green,P.A. Hessel
Near-fatal asthma: a population-based study of risk factors
Chest, 121 (2002), pp. 1407-1413
[28.]
A.F. Gelb,A. Schein,E. Nussbaum,C.M. Shinar,Y. Aelony,H. Aharonian
Risk factors for near-fatal asthma
Chest, 126 (2004), pp. 1138-1146 http://dx.doi.org/10.1378/chest.126.4.1138
[29.]
V. Plaza,J. Serra-Batlles,A. Comella,C. Badiola
Differences in asthma clinical outcomes according to the initial severity
J Asthma, 42 (2005), pp. 207-211
[30.]
E.M. Skobeloff,W.H. Spivey,S.S. St Clair,J.M. Schoffstall
The influence of age and sex on asthma admissions
JAMA, 268 (1992), pp. 3437-3440
[31.]
E. Martínez-Moragón,V. Plaza,J. Serrano,C. Picado,J.B. Gáldiz,A. López-Viña
Near-fatal asthma related to menstruation
J Allergy Clin Immunol, 113 (2004), pp. 242-244 http://dx.doi.org/10.1016/j.jaci.2003.11.002
[32.]
C.S. Murray,A. Simpson,A. Custovic
Allergens, viruses and asthma exacerbations
Proc Am Thorac Soc, 1 (2004), pp. 99-104 http://dx.doi.org/10.1513/pats.2306027
[33.]
R.E. Dales,S. Cakmak,S. Judek,T. Dann,F. Coates,J.R. Brook
Influence of outdoor aeroallergens on hospitalization for asthma in Canada
J Allergy Clin Immunol, 113 (2004), pp. 303-306 http://dx.doi.org/10.1016/j.jaci.2003.11.016
[34.]
S. Hales,S. Lewis,T. Slater,J. Crane,N. Pearce
Prevalence of asthma symptoms in relation to climate in New Zealand
Environ Health Perspect, 106 (1998), pp. 607-610
[35.]
N.W. Johnston,M.R. Sears
Asthma exacerbations. Epidemiology
[36.]
D.R. Taylor,E.D. Bateman,L.P. Boulet,H.A. Boushey,W.W. Busse,T.B. Casale
A new perspective on concepts of asthma severity and control
Eur Respir J, 32 (2008), pp. 545-554 http://dx.doi.org/10.1183/09031936.00155307
[37.]
P.G. Gibson,H. Powell,F.M. Ducharme
Differential effects of maintenance long-acting beta-agonist and inhaled corticosteroid on asthma control and asthma exacerbations
J Allergy Clin Immunol, 119 (2007), pp. 344-350 http://dx.doi.org/10.1016/j.jaci.2006.10.043
[38.]
E.F. Juniper,P.M. O’Byrne,P.J. Ferrie,D.R. King,J.N. Roberts
Measuring asthma control. Clinic questionnaire or daily diary?
Am J Respir Crit Care Med, 162 (2000), pp. 1330-1334 http://dx.doi.org/10.1164/ajrccm.162.4.9912138
[39.]
E.F. Juniper,P.M. O’Byrne,G.H. Guyatt,P.J. Ferrie,D.R. King
Development and validation of a questionnaire to measure asthma control
Eur Respir J, 14 (1999), pp. 902-907
[40.]
E.F. Juniper,K. Sevensson,A.C. Mörk,E. Stähl
Measurement properties and interpretation of three shortened versions of the asthma control questionnaire
Respir Med, 99 (2005), pp. 553-558 http://dx.doi.org/10.1016/j.rmed.2004.10.008
[41.]
R.A. Nathan,C.A. Sorkness,M. Kosinski,M. Schatz,J.T. Lim,P. Marcus
Development of the asthma control test: a survey for assessing asthma control
J Allergy Clin Immunol, 113 (2004), pp. 59-65 http://dx.doi.org/10.1016/j.jaci.2003.09.008
[42.]
M. Schatz,C.A. Sorkness,J.T. Li,P. Marcus,J.J. Murray,R.A. Nathan
Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists
J Allergy Clin Immunol, 117 (2006), pp. 549-556 http://dx.doi.org/10.1016/j.jaci.2006.01.011
[43.]
J.M. Vega,X. Badia,C. Badiola,A. López-Vinia,J.M. Olaguibel,C. Picado
Validation of the Spanish version of the Asthma Control Test (ACT)
[44.]
G.J. Rodrigo,J.P. Arcos,L.J. Nannini,H. Neffen,M. González Broin,M. Contrera
Reliability and factor analysis of the Spanish version of the Asthma Control Test
Ann Allergy Asthma Immunol, 100 (2008), pp. 17-22 http://dx.doi.org/10.1016/S1081-1206(10)60399-7
[45.]
P.P. Katz,E.H. Yelin,M.D. Eisner,P.D. Blanc
Perceived control of asthma and quality of life among adults with asthma
Ann Allergy Asthma Immunol, 89 (2002), pp. 251-258 http://dx.doi.org/10.1016/S1081-1206(10)61951-5
[46.]
C.S. Calfee,P.P. Katz,E.H. Yelin,C. Iribarren,M.D. Eisner
The influence of perceived control of asthma on health outcomes
Chest, 130 (2006), pp. 1312-1318 http://dx.doi.org/10.1378/chest.130.5.1312
[47.]
L. Laforest,E. Van Ganse,G. Devouassoux,L.M. Osman,K. Brice,J. Massol
Asthmatic patients’ poor awareness of inadequate disease control: a pharmacy-based survey
Ann Allergy Asthma Immunol, 98 (2007), pp. 146-152 http://dx.doi.org/10.1016/S1081-1206(10)60687-4
[48.]
P.L. Brand,E.J. Duiverman,H.J. Waalkens,E.E. Van Essen-Zandvliet,K.F. Kerrebijn
Peak flow variation in childhood asthma: correlation with symptoms, airways obstruction, and hyperresponsiveness during long term treatment with inhaled corticosteroids
Thorax, 54 (1999), pp. 103-107
[49.]
H.K. Reddel,G.B. Marks,C.R. Jenkins
When can personal best peak flow be determined for asthma action plans?
[50.]
K.J. Killian,R. Watson,J. Otis,T.A. St Amand,P.M. O’Byrne
Symptom perception during acute bronchoconstriction
Am J Respir Crit Care Med, 162 (2000), pp. 490-496 http://dx.doi.org/10.1164/ajrccm.162.2.9905079
[51.]
J.K. Sont,L.N. Willems,E.H. Bel,J.H. Van Krieken,J.P. Vandenbroucke,P.J. Sterk
Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment
Am J Respir Crit Care Med, 159 (1999), pp. 1043-1051 http://dx.doi.org/10.1164/ajrccm.159.4.9806052
[52.]
M.M. Pizzichini,T.A. Popov,A. Efthimiadis,P. Hussack,S. Evans,E. Pizzichini
Spontaneous and induced sputum to measure indices of airway inflammation in asthma
Am J Respir Crit Care Med, 154 (1996), pp. 866-869 http://dx.doi.org/10.1164/ajrccm.154.4.8887576
[53.]
R.H. Green,C.E. Brightling,S. McKenna,B. Hargadon,D. Parker,P. Brading
Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial
[54.]
A. Jatakanon,S. Kharitonov,S. Lim,P.J. Barnes
Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma
Thorax, 54 (1999), pp. 108-114
[55.]
P.E. Silkoff,P. McClean,M. Spino,L. Erlich,A.S. Slutsky,N. Zamel
Dose-response relationship and reproducibility of the fall in exhaled nitric oxide after inhaled beclomethasone dipropionate therapy in asthma patients
Chest, 119 (2001), pp. 1322-1328
[56.]
A.D. Smith,J.O. Cowan,K.P. Brassett,G.P. Herbison,D.R. Taylor
Use of exhaled nitric oxide measurements to guide treatment in chronic asthma
N Engl J Med, 352 (2005), pp. 2163-2173 http://dx.doi.org/10.1056/NEJMoa043596
[57.]
S.I. Jones,J. Kittelson,J.O. Cowan,E.M. Flannery,R.J. Hancox,C.R. McLachlan
The predictive value of exhaled nitric oxide measurements in assessing changes in asthma control
Am J Respir Crit Care Med, 164 (2001), pp. 738-743 http://dx.doi.org/10.1164/ajrccm.164.5.2012125
[58.]
J.M. Sippel,W.E. Holden,S.A. Tilles,M. O’Hollaren,J. Cook,N. Thukkani
Exhaled nitric oxide levels correlate with measures of disease control in asthma
J Allergy Clin Immunol, 106 (2000), pp. 645-650 http://dx.doi.org/10.1067/mai.2000.109618
[59.]
A.F. Gelb,C.F. Taylor,C.M. Shinar,C. Gutiérrez,N. Zamel
Role of spirometry and exhaled nitric oxide to predict exacerbations in treated asthmatics
Chest, 129 (2006), pp. 1492-1499 http://dx.doi.org/10.1378/chest.129.6.1492
[60.]
E. Paraskakis,C. Brindicci,L. Fleming,R. Krol,S.A. Kharitonov,N.M. Wilson
Measurement of bronchial and alveolar nitric oxide production in normal children and children with asthma
Am J Respir Crit Care Med, 174 (2006), pp. 260-267 http://dx.doi.org/10.1164/rccm.200506-962OC
[61.]
H.L. Petsky,C.J. Cates,A.M. Li,J.A. Kynaston,C. Turner,A.B. Chang
Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults
Cochrane Database Syst Rev, (2008),
[62.]
A.D. Smith,J.O. Cowan,S. Filsell,C. McLachlan,G. Monti-Sheehan,P. Jackson
Diagnosing asthma. Comparisons between exhaled nitric oxide measurements and conventional tests
Am J Respir Crit Care Med, 169 (2004), pp. 473-478 http://dx.doi.org/10.1164/rccm.200310-1376OC
[63.]
S.A. Kharitonov,P.J. Barnes
Exhaled markers of pulmonary disease
Am J Respir Crit Care Med, 163 (2001), pp. 1693-1722 http://dx.doi.org/10.1164/ajrccm.163.7.2009041
[64.]
L.P. Boulet,V. Boulet,J. Milot
How should we quantify asthma control? A proposal
Chest, 122 (2002), pp. 2217-2223
[65.]
J.M. FitzGerald,P.G. Gibson
Asthma exacerbations. 4: Prevention
[66.]
R.A. Pauwels,S. Pedersen,W.W. Busse,W.C. Tan,Y.Z. Chen,S.V. Ohlsson
Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial
[67.]
A. Woolcock,B. Lundback,N. Ringdal,L.A. Jacques
Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids
Am J Respir Crit Care Med, 153 (1996), pp. 1481-1488 http://dx.doi.org/10.1164/ajrccm.153.5.8630590
[68.]
R.A. Pauwels,C.G. Lofdahl,D.S. Postma,A.E. Tattersfield,P. O’Byrne,P.J. Barnes
Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol And Corticosteroids Establishing Therapy (FACET) International Study Group
N Engl J Med, 337 (1997), pp. 1405-1411 http://dx.doi.org/10.1056/NEJM199711133372001
[69.]
E.D. Bateman,H.A. Boushey,J. Bousquet,W.W. Busse,T.J. Clark,R.A. Pauwels
Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma Control Study
Am J Respir Crit Care Med, 170 (2004), pp. 836-844 http://dx.doi.org/10.1164/rccm.200401-033OC
[70.]
M. Masoli,M. Weatherall,S. Holt,R. Beasley
Moderate dose inhaled corticosteroids plus salmeterol versus higher doses of inhaled corticosteroids in symptomatic asthma
[71.]
S.W. Stoloff,D.A. Stempel,J. Meyer,R.H. Stanford,J.R. Carranza Rosenzweig
Improved refill persistence with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies
J Allergy Clin Immunol, 113 (2004), pp. 245-251 http://dx.doi.org/10.1016/j.jaci.2003.10.011
[72.]
P.M. O’Byrne,E. Adelroth
Beta2 déjà vu
[73.]
M.J. Vaquerizo,P. Casan,J. Castillo,M. Perpiñá,J. Sanchis,V. Sobradillo
Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma
Thorax, 58 (2003), pp. 204-210
[74.]
H. Milgrom,R.B. Fick,J.Q. Su,J.D. Reimann,R.K. Bush,M.L. Watrous
Treatment of allergic asthma with monoclonal anti-IgE antibody. rhuMAb-E25 Study Group
N Engl J Med, 341 (1999), pp. 1966-1973 http://dx.doi.org/10.1056/NEJM199912233412603
[75.]
M. Soler,J. Matz,R. Townley,R. Buhl,J. O’Brien,H. Fox
The anti-IgE antibody omalizumab reduces exacerbations and steroid requirement in allergic asthmatics
Eur Respir J, 18 (2001), pp. 254-261
[76.]
H.A. Boushey,C.A. Sorkness,T.S. King,S.D. Sullivan,J.V. Fahy,S.C. Lazarus
Daily versus as-needed corticosteroids for mild persistent asthma
N Engl J Med, 352 (2005), pp. 1519-1528 http://dx.doi.org/10.1056/NEJMoa042552
[77.]
A. Papi,G.W. Canonica,P. Maestrelli,P. Paggiaro,D. Olivieri,E. Pozzi
Rescue use of beclomethasone and albuterol in a single inhaler for mild asthma
N Engl J Med, 356 (2007), pp. 2040-2052 http://dx.doi.org/10.1056/NEJMoa063861
[78.]
P.M. O’Byrne,H. Bisgaard,P.P. Godard,M. Pistolesi,M. Palmqvist,Y. Zhu
Budesonide/formoterol combination as both maintenance and reliever medication in asthma
Am J Respir Crit Care Med, 171 (2005), pp. 129-136 http://dx.doi.org/10.1164/rccm.200407-884OC
[79.]
C. Vogelmeier,A. D’Urzo,R. Pauwels,J.M. Merino,M. Jaspal,S. Boutet
Budesonide/formoterol maintenance and reliever therapy: an effective asthma treatment option?
Eur Respir J, 26 (2005), pp. 819-828 http://dx.doi.org/10.1183/09031936.05.00028305
[80.]
K.F. Rabe,T. Atienza,P. Magyar,P. Larsson,C. Jorup,U. Lalloo
Effect of budesonide in combination with formoterol for reliever therapy in asthma exacerbations: a randomised controlled, double-blind study
[81.]
L. Jayaram,M.M. Pizzichini,R.J. Cook,L.P. Boulet,C. Lemière,E. Pizzichini
Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations
Eur Respir J, 27 (2006), pp. 483-494 http://dx.doi.org/10.1183/09031936.06.00137704
[82.]
C.G. Lofdahl,T.F. Reiss,J.A. Leff,E. Israel,M.J. Noonan,A.F. Finn
Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients
BMJ, 319 (1999), pp. 87-90
[83.]
A. Deykin,M.E. Wechsler,H.A. Boushey,V.M. Chinchilli,S.J. Kunselman,T.J. Craig
Combination therapy with a long-acting b-agonist and a leukotriene antagonist in moderate asthma
Am J Respir Crit Care Med, 175 (2007), pp. 228-234 http://dx.doi.org/10.1164/rccm.200601-112OC
[84.]
L. Bjermer,H. Bisgaard,J. Bousquet,L.M. Fabbri,A.P. Greening,T. Haahtela
Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial
[85.]
M.J. Abramson,R.M. Puy,J.M. Weiner
Is allergen immunotherapy effective in asthma? A meta-analysis of randomized controlled trials
Am J Respir Crit Care Med, 151 (1995), pp. 969-974 http://dx.doi.org/10.1164/ajrccm/151.4.969
[86.]
O. Abadoglu,D. Mungan,G. Pasaoglu,G. Celik,Z. Misirligil
Influenza vaccination in patients with asthma: effect on the frequency of upper respiratory tract infections and exacerbations
J Asthma, 41 (2004), pp. 279-283
[87.]
C. Christy,C.A. Aligne,P. Auinger,T. Pulcino,M. Weitzman
Effectiveness of influenza vaccine for the prevention of asthma exacerbations
Arch Dis Child, 89 (2004), pp. 734-735 http://dx.doi.org/10.1136/adc.2003.030999
[88.]
A. Sheikh,A. Alves,S. Dhami
Pneumococcal vaccine for asthma
Cochrane Database of Systematic Reviews, 1 (2002),
[89.]
P.G. Gibson,J. Coughlan,A.J. Wilson,M. Abramson,A. Bauman,M.J. Hensley
Self-management education and regular practitioner review for adults with asthma
Cochrane Database Syst Rev, 62 (2000),
[90.]
J.P. Guevara,F.M. Wolf,C.M. Grum,N.M. Clark
Effects of educational interventions for self management of asthma in children and adolescents: systematic review and meta-analysis
[91.]
S.L. Janson,J.V. Fahy,J.K. Covington,S.M. Paul,W.M. Gold,H.A. Boushey
Effects of individual self management education on clinical, biological, and adherence outcomes in asthma
Am J Med, 115 (2003), pp. 620-626
[92.]
N.M. Clark,F. Nothwehr,M. Gong,D. Evans,L.A. Maiman,M.E. Hurwitz
Physician-patient partnership in managing chronic illness
Acad Med, 70 (1995), pp. 957-960
[93.]
K.R. Chapman,L. Walker,S. Cluley,L. Fabbri
Improving patient compliance with asthma therapy
[94.]
R.J. Adams,K. Boath,S. Homan,D.A. Campbell,R.E. Ruffin
A randomized trial of peak-flow and symptom-based action plans in adults with moderate-to-severe asthma
Respirology, 6 (2001), pp. 297-304
[95.]
R. Horne
Compliance, adherence, and concordance: implications for asthma treatment
Chest, 130 (2006), pp. S65-S72
[96.]
J. Douglass,R. Aaroni,D. Goeman,K. Stewart,S. Sawyer,F. Thien
A qualitative study of action plans for asthma
BMJ, 324 (2002), pp. 1003-1005
[97.]
W.N. Hopman,N. Garvey,J. Olajos-Clow,A. White-Markham,M.D. Lougheed
Outcomes of asthma education: results of a multisite evaluation
Can Respir J, 11 (2004), pp. 291-297
[98.]
A. Lahdensuo
Guided self management of asthma – How to do it
BMJ, 319 (1999), pp. 759-760
[99.]
M.R. Partridge,S.R. Hill
Enhancing care for people with asthma: the role of communication, education, training and self-management. 1998 World Asthma Meeting Education and Delivery of Care Working Group
Eur Respir J, 16 (2000), pp. 333-348
[100.]
M.J. Abramson,M.J. Bailey,F.J. Couper,J.S. Driver,O.H. Drummer,A.B. Forbes
Are asthma medications and management related to deaths from asthma?
Am J Respir Crit Care Med, 163 (2001), pp. 12-18 http://dx.doi.org/10.1164/ajrccm.163.1.9910042
[101.]
J.R. Smith,M. Mugford,R. Holland,B. Candy,M.J. Noble,B.D. Harrison
A systematic review to examine the impact of psycho-educational interventions on health outcomes and costs in adults and children with difficult asthma
Health Technol Assess, 9 (2005), pp. 1-182
[102.]
P.G. Gibson,H. Powell
Written action plans for asthma: an evidence-based review of the key components
Thorax, 59 (2004), pp. 94-99
[103.]
A.T. Ten Brinke,P.J. Sterk,A.A.M. Masclee,P. Spinhoven,J.T. Schimdt,A.H. Zwinderman
Risk factors of frequent exacerbations in difficult-to-treat asthma
Eur Respir J, 26 (2005), pp. 812-818 http://dx.doi.org/10.1183/09031936.05.00037905
[104.]
J. Serrano,V. Plaza,B. Sureda,J. De Pablo,C. Picado,S. Bardagi
Alexithymia: a relevant psychological variable in near-fatal asthma
Eur Respir J, 28 (2006), pp. 296-302 http://dx.doi.org/10.1183/09031936.06.00008105
[105.]
J. Côté,D.M. Bowie,P. Robichaud,J.G. Parent,L. Battisti,L.P. Boulet
Evaluation of two different educational interventions for adult patients consulting with acute asthma exacerbation
Am J Respir Crit Care Med, 63 (2001), pp. 1415-1419
[106.]
S.D. Edmond,C.R. Reed,L.G. Graff,S. Clark,C.A. Camargo
Asthma education in the emergency department
Ann Emerg Med, 36 (2000), pp. 2004-2011
[107.]
L.M. Osman,C. Calder,D.J. Godden,J.A. Friend,L. McKenzie,J.S. Legge
A randomised trial of self-management planning for adult patients admitted to hospital with acute asthma
Thorax, 57 (2002), pp. 869-874
[108.]
C.L. Emerman,R. Cydulka
Effect of pulmonary function test on the management of acute asthma
Arch Intern Med, 155 (1995), pp. 2225-2228
[109.]
I. Dahlén,C. Janson
Anxiety and depression are related to the outcome of emergency treatment in patients with obstructive pulmonary disease
Chest, 122 (2002), pp. 1633-1637
[110.]
G.J. Rodrigo,C. Rodrigo,L.J. Nannini
Asma fatal o casi fatal: ¿entidad clínica o manejo inadecuado?
Arch Bronconeumol, 40 (2004), pp. 24-33
[111.]
W.O. Spitzer,S. Suissa,P. Ernst,R.I. Horwitz,B. Habbick,D. Cockcroft
The use of beta-agonist and the risk of death and near death from asthma
N Engl J Med, 326 (1992), pp. 501-506 http://dx.doi.org/10.1056/NEJM199202203260801
[112.]
P.M. Sturdy,C.R. Victor,H.R. Anderson,J.M. Bland,B.K. Butland,B.D. Harrison
Psychological, social and health behaviour risk factors for deaths certified as asthma: a national case-control study
Thorax, 57 (2002), pp. 1034-1039
[113.]
C.C. Teerlink,M.J. Hegewald,L.A. Cannon-Albright
A genealogical assessment of heritable predisposition to asthma mortality
Am J Respir Crit Care Med, 176 (2007), pp. 865-870 http://dx.doi.org/10.1164/rccm.200703-448OC
[114.]
E.R. McFadden,R. Kisser,W.J. De Groot
Acute bronchial asthma: relations between clinical and physiological manifestations
N Engl J Med, 288 (1973), pp. 221-225 http://dx.doi.org/10.1056/NEJM197302012880501
[115.]
R.M. Nowak,M.I. Pensier,D.D. Sarkar,J.A. Anderson,P.A. Kvale,A.E. Ortiz
Comparison of peak expiratory flow and FEV1 admission criteria for acute bronchial asthma
Ann Emerg Med, 11 (1982), pp. 64-69
[116.]
G. Rodrigo,C. Rodrigo
Assessment of the patient with acute asthma in the emergency department. A factor analytic study
Chest, 104 (1993), pp. 1325-1328
[117.]
R.A. Silverman,E. Flaster,P.L. Enright,S.G. Simonson
FEV1 performance among patients with acute asthma. Results from a multicenter clinical trial
Chest, 131 (2007), pp. 164-171 http://dx.doi.org/10.1378/chest.06-0530
[118.]
M.G. Pearson,D.P. Spence,I. Ryland,B.D. Harrison
Value of pulsus paradoxus in assessing acute severe asthma. British Thoracic Society Standards of Care Committee
BMJ, 307 (1993), pp. 659
[119.]
G.D. Jay,K. Onuma,R. Davis,M.H. Chen,A. Mansell,D. Steele
Analysis of physician ability in the measurement of pulsus paradoxus by sphygmomanometry
Chest, 118 (2000), pp. 348-352
[120.]
M. Gill,S. Walker,A. Khan,S.M. Green,L. Kim,S. Gray
Exhaled nitric oxide levels during acute asthma exacerbation
Acad Emerg Med, 12 (2005), pp. 579-586 http://dx.doi.org/10.1197/j.aem.2005.01.018
[121.]
G. Rodrigo,C. Rodrigo
A new index for early prediction of hospitalization in. patients with acute asthma
Am J Emerg Med, 15 (1997), pp. 8-13
[122.]
C. Rodrigo,G. Rodrigo
Therapeutic response patterns to high and cumulative doses of salbutamol in acute severe asthma
Chest, 113 (1998), pp. 593-598
[123.]
G. Rodrigo,C. Rodrigo
Early prediction of poor response in acute asthma patients in the emergency department
Chest, 114 (1998), pp. 1016-1021
[124.]
M. McCarren,R.J. Zalenski,M. McDermott,K. Kaur
Predicting recovery from acute asthma in an emergency diagnostic and treatment unit
Acad Emerg Med, 7 (2000), pp. 28-35
[125.]
R.Y. Lin,D. Sauter,T. Newman,J. Sirleaf,J. Walters,M. Tavakol
Continuous versus intermittent albuterol nebulization in the treatment of acute asthma
Ann Emerg Med, 22 (1993), pp. 1847-1853
[126.]
G.S. Rudnitsky,R.S. Eberlein,J.M. Schoffstall,J.E. Mazur,W.H. Spivey
Comparison of intermittent and continuously nebulized albuterol for treatment of asthma in an urban emergency department
Ann Emerg Med, 22 (1993), pp. 1842-1846
[127.]
C. Reisner,A. Kotch,G. Dworkin
Continuous versus frequent intermittent nebulization of albuterol in acute asthma: a randomized, prospective study
Ann Allergy Asthma Immunol, 75 (1995), pp. 41-47
[128.]
M.B. Dolovich,R.C. Ahrens,D.R. Hess,P. Anderson,R. Dhand,J.L. Rau
Device selection and outcomes of aerosol therapy: evidence-based guidelines
[129.]
C.J. Cates,J.A. Crilly,B.H. Rowe
Holding chambers (spacers) versus nebulisers for beta-agonist treatment of acute asthma
Cochrane Database of Systematic Reviews, 2 (2006),
[130.]
B.H. Rowe,C. Spooner,F.M. Ducharme,J.A. Bretzlaff,G.W. Bota
Early emergency department treatment of acute asthma with systemic corticosteroids
Cochrane Database of Systematic Reviews, (2001),
[131.]
J. Kolbe,W. Fergusson,J. Garret
Rapid onset asthma: a severe but uncommon manifestation
Thorax, 53 (1998), pp. 241-247
[132.]
J.W. Chien,R. Ciufo,R. Novak,M. Skowronski,J. Nelson,A. Coreno
Uncontrolled oxygen administration and respiratory failure in acute asthma
Chest, 117 (2000), pp. 728-733
[133.]
G.J. Rodrigo,M. Rodríguez-Verde,V. Peregalli,C. Rodrigo
Effects of short-term 28% and 100% oxygen in PaCO2 and peak expiratory flow rate in acute asthma. A randomized trial
Chest, 124 (2003), pp. 1312-1317
[134.]
L. Strauss,R. Hejal,G. Galan,L. Dixon,E.R. McFadden
Observations of the effects of aerosolized albuterol in acute asthma
Am J Respir Crit Care Med, 155 (1997), pp. 545-548
[135.]
A. Travers,A.P. Jones,K. Kelly,S.J. Barker,C.A. Camargo,B.H. Rowe
Intravenous beta2-agonists for acute asthma in the emergency department
Cochrane Database of Systematic Reviews, 1 (2001),
[136.]
K.B. Newman,S. Milne,C. Hamilton,K. Hall
A comparison of albuterol administered by metered-dose inhaler and spacer with albuterol by nebulizer in adults presenting to an urban emergency department with acute asthma
Chest, 121 (2002), pp. 1036-1041
[137.]
M.H. Osmond,M. Gazarian,R.L. Henry,T.J. Clifford
Barriers to metered-dose inhaler/spacer use in Canadian pediatric emergency departments: a national survey
Acad Emerg Med, 14 (2007), pp. 1106-1113 http://dx.doi.org/10.1197/j.aem.2007.05.009
[138.]
K.F. Hurley,J. Sargeant,J. Duffy,I. Sketris,D. Sinclair,J. Ducharme
Perceptual reasons for resistance to change in the emergency department use of holding chambers for children with asthma
[139.]
G.J. Rodrigo,C. Rodrigo
Continuous vs. intermittent beta-agonists in the treatment of acute adult asthma: a systematic review with meta-analysis
Chest, 122 (2002), pp. 160-165
[140.]
Camargo CA, Spooner CH, Rowe BH. Continuous versus intermittent beta-agonists for acute asthma. Cochrane Database of Systematic Reviews. 2003b;4:CD001115. DOI: 10.1002/14651858.CD001115.
[141.]
G.J. Rodrigo,H. Neffen,F.D. Colodenco,J.A. Castro-Rodriguez
Formoterol for acute asthma in the emergency department: A systematic review with meta-analysis
Ann Allergy Asthma Immunol, 104 (2010), pp. 247-252 http://dx.doi.org/10.1016/j.anai.2009.11.064
[142.]
R. Nowak,C.H. Emerman,J.P. Hanrahanc,M.V. Parsey,N.A. Hanania,R. Claus
A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults
Am J Emerg Med, 24 (2006), pp. 259-267 http://dx.doi.org/10.1016/j.ajem.2006.01.027
[143.]
G.J. Rodrigo,L.J. Nannini
Comparison between nebulized adrenaline and beta2 agonists for the treatment of acute asthma. A meta-analysis of randomized trials
Am J Emerg Med, 24 (2006), pp. 217-222 http://dx.doi.org/10.1016/j.ajem.2005.10.008
[144.]
G.J. Rodrigo,J.A. Castro-Rodríguez
Anticholinergics in the treatment of children and adults with acute asthma: a systematic review with meta-analysis
[145.]
G. Rodrigo,C. Rodrigo
Corticosteroids in the Emergency Department therapy of acute adult asthma. An evidence-based evaluation
Chest, 116 (1999), pp. 285-295
[146.]
B.H. Rowe,C.H. Spooner,F.M. Ducharme,G.W. Bota
Corticosteroids for preventing relapse following acute exacerbations of asthma
Cochrane Database of Systematic Reviews, 3 (2007),
[147.]
F.A. Lederle,R.E. Pluhar,A.M. Joseph,D.E. Niewoehner
Tapering of corticosteroid therapy following exacerbation of asthma. A randomized, double-blind, placebo-controlled trial
Arch Intern Med, 147 (1987), pp. 2201-2203
[148.]
B.R. O’Driscoll,S. Kalra,C.A.C. Pickering,K.B. Carroll,A.A. Woodcock,M. Wilson
Double-blind trial of steroid tapering in acute asthma
Lancet, 341 (1993), pp. 324-327
[149.]
M.Q. Hatton,A.S. Vathenen,M.J. Allen,S. Davies,N.J. Cooke
A comparison of “abruptly stopping” with “tailing off” oral corticosteroids in acute asthma
Respir Med, 89 (1995), pp. 101-104
[150.]
G.J. Rodrigo
Rapid effects of inhaled corticosteroids in acute asthma. An evidence-based evaluation
Chest, 130 (2006), pp. 1301-1311 http://dx.doi.org/10.1378/chest.130.5.1301
[151.]
B.H. Rowe,J.A. Bretzlaff,C. Bourdon,G.W. Bota,C.A. Camargo
Magnesium sulfate for treating exacerbations of acute asthma in the emergency department
Cochrane Database of Systematic Reviews, 1 (2000),
[152.]
R.A. Silverman,H. Osborn,J. Runge,E.J. Gallagher,W. Chiang,J. Feldman
IV magnesium sulfate in the treatment of acute severe asthma. A multicenter randomized controlled trial
Chest, 122 (2002), pp. 489-497
[153.]
M. Blitz,S. Blitz,R. Beasely,B.M. Diner,R. Hughes,J.A. Knopp
Inhaled magnesium sulphate in the treatment of acute asthma
Cochrane Database of Systematic Reviews, 4 (2005),
[154.]
G.J. Rodrigo,L.J. Nannini
Is there a place for nebulized magnesium sulfate in the treatment of acute asthma? A systematic review
Curr Ther, 1 (2006), pp. 181-185
[155.]
K. Parameswaran,J. Belda,B.H. Rowe
Addition of intravenous aminophylline to beta2-agonists in adults with acute asthma
Cochrane Database of Systematic Reviews, 4 (2000),
[156.]
G. Rodrigo,C. Pollack,C. Rodrigo,B.H. Rowe
Heliox for nonintubated acute asthma patients
Cochrane Database of Systematic Reviews, 4 (2006), pp. CD002884
[157.]
C.A. Camargo,H.A. Smithline,M.O. Malice,S.A. Green,T.F. Reiss
Randomized controlled trial of intravenous montelukast in acute asthma
Am J Respir Crit Care Med, 167 (2003), pp. 528-533 http://dx.doi.org/10.1164/rccm.200208-802OC
[158.]
A.C. Cylly,A. Kara,T. Ozdemir,C. Ogus,K.H. Gulkesen
Effects of oral montelukast on airway function in acute asthma
Respir Med, 97 (2003), pp. 533-536
[159.]
S.L. Johnston,F. Blasi,P.N. Black,R.J. Martin,D.J. Farrel,R.B. Nieman
The effect of telithromycin in acute exacerbations of asthma
N Engl J Med, 354 (2006), pp. 1589-1600 http://dx.doi.org/10.1056/NEJMoa044080
[160.]
K.S. Joseph,L. Blais,P. Ernst,S. Suissa
Increased morbidity and mortality related to asthma among asthmatic patients who use major tranquillisers
BMJ, 312 (1996), pp. 79-82
[161.]
A. Soroksky,D. Stav,I. Shpirer
A pilot prospective, randomized, placebo-controlled trial of bilevel positive airway pressure in acute asthmatic attack
Chest, 123 (2003), pp. 1018-1025
[162.]
A. Grunfeld,J.M. Fitzgerald
Discharge considerations in acute asthma
Can Respir J, 3 (1996), pp. 322-324
[163.]
R. Darioli,C. Perret
Mechanical controlled hypoventilation in status asthmaticus
Am Rev Respir Dis, 129 (1984), pp. 385-387 http://dx.doi.org/10.1164/arrd.1984.129.3.385
[164.]
D.V. Tuxen
Permissive hypercapnic ventilation
Am J Respir Crit Care Med, 150 (1994), pp. 870-874 http://dx.doi.org/10.1164/ajrccm.150.3.8087364
[165.]
J.A. Castro-Rodríguez,C.J. Holberg,A.L. Wright,F.D. Martínez
A clinical index to define risk of asthma in young children with recurrent wheezing
Am J Respir Crit Care Med, 162 (2000), pp. 1403-1406 http://dx.doi.org/10.1164/ajrccm.162.4.9912111
[166.]
S.V. Mehta,P.C. Parkin,D. Stephens,K.A. Keogh,S. Schuh
Oxygen saturation as a predictor of prolonged, frequent bronchodilator therapy in children with acute asthma
J Pediatr, 145 (2004), pp. 641-645 http://dx.doi.org/10.1016/j.jpeds.2004.06.072
[167.]
K.A. Keogh,C. Macarthur,P.C. Parkin,D. Stephens,R. Arseneault,O. Tennis
Predictors of hospitalization in children with acute asthma
J Pediatr, 139 (2001), pp. 273-277 http://dx.doi.org/10.1067/mpd.2001.116282
[168.]
D. Pavón,J.A. Castro-Rodríguez,L. Rubilar,G. Girardi
Relation between pulse oximetry and clinical score in children with acute wheezing less than 24 months of age
Pediatr Pulmonol, 27 (1999), pp. 423-427
[169.]
J.A. Castro-Rodríguez,G.J. Rodrigo
Beta-agonists through metered-dose inhaler with valved holding chamber versus nebulizer for acute exacerbation of wheezing or asthma in children under 5 years of age: a systematic review with meta-analysis
J Pediatr, 145 (2004), pp. 172-177 http://dx.doi.org/10.1016/j.jpeds.2004.04.007
[170.]
J.C. Carl,T.R. Myers,H.L. Kirchner,C.M. Kercsmar
Comparison of racemic albuterol and levalbuterol for treatment of acute asthma
[171.]
R.J. Scarfone,S.M. Fuchs,A.L. Nager,S.A. Shane
Controlled trial of oral prednisone in the emergency department treatment of children with acute asthma
Pediatrics, 92 (1993), pp. 513-583
[172.]
D.M. Gries,D.R. Moffitt,E. Pulos,E.R. Carter
A single dose of intramuscularly administered dexamethasone acetate is as effective as oral prednisone to treat asthma exacerbations in young children
J Pediatr, 136 (2000), pp. 298-303 http://dx.doi.org/10.1067/mpd.2000.103353
[173.]
A. Mitra,D. Bassler,K. Watts,T.J. Lasserson,F.M. Ducharme
Intravenous aminophylline for acute severe asthma in children over two years receiving inhaled bronchodilators
Cochrane Database of Systematic Reviews, 2 (2005),
[174.]
S.R. Smith,B.H. Baty,D. Hodge
Validation of the pulmonary score. An asthma severity score for children
Acad Emerg Med, 9 (2002), pp. 99-104
[175.]
M.S. Rhanana,R.P. Geilen,S. Singui,M. Van der Akker,N.H. Chavannes
Which clinical signs and symptoms predict hypoxemia in acute childhood asthma?
Indian J Pediatr, 73 (2006), pp. 771-775
[176.]
W. Carroll,W. Lenney
Drug therapy in the management of acute asthma
Arch Dis Child Educ Pract Ed, 92 (2007), pp. 82-86
[177.]
F. Qureshi,A. Zaritsky,C. Welch,T. Meadows,B.L. Burke
Clinical efficacy of racemic albuterol versus levalbuterol for the treatment of acute pediatric asthma
[178.]
M.E. Ralston,M.S. Euwema,K.R. Knecht
Comparison of levalbuterol and racemic albuterol combined with ipratropium bromide in acute pediatric asthma: a randomized controlled trial
[179.]
J.M. Becker,A. Aroraq,R.J. Scarfone,N.D. Spector,M.E. Fontana-Penn,E. Gracely
Oral versus intravenous corticosteroids in children hospitalized with asthma
J Allergy Clin Immunol, 103 (1999), pp. 586-590
[180.]
T.A. Bradshaw,S.P. Matusiewicz,G.K. Crompton,J.A. Innes,A.P. Greening
Intravenous magnesium sulphate provides no additive benefit to standard management in acute asthma
Respir Med, 102 (2008), pp. 143-149 http://dx.doi.org/10.1016/j.rmed.2007.07.022
[181.]
J.J. Zorc,R.J. Scarfone,Y. Li,T. Hong,M. Harmelin,L. Grunstein
Scheduled follow-up after a pediatric emergency department visit for asthma: a randomized trial
Pediatrics, 111 (2003), pp. 495-502
Copyright © 2010. Sociedad Española de Neumología y Cirugía Torácica
Idiomas
Archivos de Bronconeumología

Suscríbase al Newsletter

Opciones de artículo
Herramientas
es en
Política de cookies Cookies policy
Utilizamos cookies propias y de terceros para mejorar nuestros servicios y mostrarle publicidad relacionada con sus preferencias mediante el análisis de sus hábitos de navegación. Si continua navegando, consideramos que acepta su uso. Puede cambiar la configuración u obtener más información aquí. To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here.
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?